Augmented Reality on EchoPixel allows doctors to examine organs of patients in 3D

EchoPixel The company has developed technology that allows doctors to study the internal structure of the patient in 3D based on the scan, obtained by computed tomography. Instead of the usual two-dimensional slices experts have access to an interactive three-dimensional environment.

The doctor can study the structure of the patient's organs on the screen of the monitor using a special 3D-glasses augmented reality and stylus, allowing manipulate virtual bodies in three-dimensional space.





Interested in detail (tumor, polyp, tissue damage) can twist and consider all sides. This information from the scans can be processed for the convenience - for example, increase or decrease the scale, or even print a selected portion of the tissue or organ of the 3D-printer, to examine him physically

. The increase is especially help in finding problems in the infant body. Clinical trials of the technology showed that doctors were able to find it with the help of more than 90% of congenital heart defects, at a cost of 40% less time. Also, it can help a lot easier to pick up the tools that will be used during surgery. For example, the average time of the selection of the diameter of the stents (tubes, introduced into the ducts to prevent blockage) was reduced from 40 minutes to 2.

Due to the fact that instead of a virtual reality helmet use augmented reality glasses, the surgeon can use the system directly during operation, without removing the lenses and occasionally glancing at the monitor. In the future, the company plans to use technology as a remote manipulator robots that will do the cuts and other actions with great precision, while the surgeon will manage them using the actions in the virtual model.



The startup has received funding in the amount of $ 5, 8 million. His technology it offers everyone a subscription, which costs $ 25,000 per year.

EchoPixel already received approval from the Office of sanitary inspection by the Food and Drug Administration and are now working on obtaining licenses in European and Asian countries.

Source: geektimes.ru/post/275424/